Get the Daily Brief
Latest Biotech News
Peter Marks joins Lilly – ex‑CBER chief moves to industry
Peter Marks, the former director of the FDA’s Center for Biologics Evaluation and Research (CBER), will join Eli Lilly as senior vice president of molecule discovery and head of infectious...
Lexeo and FDA signal faster route for Friedreich’s ataxia gene therapy
Lexeo Therapeutics said FDA feedback could allow an accelerated approval pathway for LX‑2006, its gene therapy for Friedreich’s ataxia cardiomyopathy, if patient data from multiple ongoing studies...
Asimov rolls out stable AAV producer lines – a manufacturing inflection
Asimov launched its AAV Edge Stable Producer system, offering clonal HEK293 producer cell lines that integrate essential viral genes to enable high‑titer, stable AAV manufacture without repeated...
Mytos opens automated CDMO for stem‑cell derived therapies
Mytos launched an automated CDMO built around its iDEM automation technology at the Cell and Gene Therapy Catapult’s Stevenage site, targeting scalable manufacture of stem‑cell derived therapies....
Insilico publishes LEGION AI workflow – scale and IP defense in discovery
Insilico Medicine released a preprint describing LEGION (Latent Enumeration, Generation, Integration, Optimization and Navigation), an AI workflow designed to enumerate and defend vast regions of...
Soufflé Therapeutics rises with $200M — RNA siRNA startup backed by Langer family
Soufflé Therapeutics, an RNA therapeutics company co‑founded by Moderna co‑founder Bob Langer, launched with a $200 million Series A and strategic partnerships with Big Pharma to develop targeted...
2025 Nobel Prizes Spotlight Immune System and Chemistry Breakthroughs
The 2025 Nobel Prizes have highlighted landmark scientific achievements reshaping biotechnology and medicine. The Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell,...
Eli Lilly Appoints Former FDA Vaccine Chief to Lead Infectious Disease Research
Eli Lilly has named Peter Marks, former Director of the FDA’s Center for Biologics Evaluation and Research (CBER), as Senior Vice President of Molecule Discovery and Head of Infectious Disease....
NanoPhoria Secures Record €83.5 Million Series A for Heart Failure Peptide Therapy
Italian biotech NanoPhoria Bioscience closed Italy’s largest-ever Series A financing in biotech, raising €83.5 million ($97.6 million) to advance NP-MP1, a novel peptide therapy targeting heart...
AI and Multiomics Reveal Physiological Adaptations in Spaceflight Missions
A comprehensive integrative multiomics analysis of astronaut biospecimens from Inspiration4, Polaris Dawn, and Ax-2 missions has unveiled consistent molecular signatures associated with...
Advances in AI-Driven Drug Discovery and Cancer Therapy Development
Recent developments in artificial intelligence are revolutionizing drug discovery and cancer treatment strategies. Insilico Medicine introduced LEGION, a hybrid AI workflow seamlessly integrating...
Regulatory and Market Movements in Biotech Financing and Therapy Development
The biotech financing landscape shows dynamic activity with substantial funds raised and key regulatory milestones achieved. TCG Crossover closed a $1.3 billion fund targeting promising biotech...
Breakthroughs in Cancer Immunotherapy and Molecular Targeting
Groundbreaking research is redefining approaches to cancer immunotherapy and molecular oncology. Lund University researchers identified the immune checkpoint molecule SLAMF6 as an acute myeloid...
Innovations in Genomic Mapping and Neuroscience Assisted by AI
Cutting-edge artificial intelligence is transforming neuroscience and genomics by enabling unprecedented resolution in brain mapping and variant interpretation. Researchers at UCSF and the Allen...
Emerging Therapeutics and Clinical Advances in Metabolic and Cardiovascular Diseases
Recent studies present promising advancements in managing metabolic and cardiovascular conditions. A meta-analysis reported that glucagon-like peptide-1 (GLP-1) receptor agonists substantially...
Nobel Prize Awarded for Regulatory T Cell Discoveries
The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their foundational work on regulatory T cells (Tregs) and peripheral...
AI-Enabled Advances in Cancer and Biotech Discovery
Cutting-edge artificial intelligence tools are transforming biomedical research, featuring prominently in oncology and drug discovery. Researchers have developed AI models that predict hematologic...
Gene Therapy Progress and Clinical Pipeline Updates
Notable advances in gene therapy include accelerated FDA approvals and clinical trial readiness. Lexeo Therapeutics anticipates a faster biologics license application (BLA) pathway for its...
Immunotherapy and Antibody Developments in Oncology
Innovative antibody-based therapies are advancing cancer treatment. Regeneron reported positive Phase III data for Libtayo, a PD-1 inhibitor, significantly reducing recurrence risks in high-risk...
Breakthroughs in Neurodegenerative and Brain Disease Understanding
Recent studies provide deeper insights into neurological disorders. A novel nanoparticle therapy restored blood-brain barrier function, facilitating amyloid-beta clearance and cognitive recovery...